We showed earlier that exposing mixtures of NAD and diphtheria toxin fragment A to ultraviolet radiation (253.7 nm) induced the formation of covalently linked proteinligand photoproducts. Here we report that when [carbonyl-14C]NAD was employed in such procedures, the efficiency of labeling of the protein approached 1 mol/mol, and at least 94% of the incorporated label was associated with a single residue, glutamic acid at position 148. Fragment A photolabeled in this manner was enzymically inactive. The efficiency of photolabeling was much lower (<0.2 mol/mol) when NAD radiolabeled in either the adenine moiety or the adenylate phosphate was used, and the label was attached to different site(s) within fragment A. Efficient photochemical transfer of label from [carbonyl-'4C]NAD occurred under identical conditions with the nucleotide-free form of whole diphtheria toxin, CRM-45, or activated exotoxin A from Pseudomonas aeruginosa, but not with nucleotide-bound diphtheria toxin, CRM-197, native exotoxin A, or any of several NAD-linked dehydrogenases. On the basis of these and other results we suggest that part or all of the nicotinamide moiety of NAD is efficiently transferred to glutamate-148 of fragment A under the influence of ultraviolet irradiation and that this residue is located within the nicotinamide subsite. This location implies that glutamate-148 is at or near the catalytic center of the toxin. Our data provide direct evidence for the location of the NAD site in an ADP-ribosylating toxin and demonstrate highly efficient and specific photo-Several bacterial exotoxins act by catalyzing transfer of the ADP-ribose moiety of NAD into covalent linkage with specific target proteins of mammalian cells. For both diphtheria toxin (DT) and exotoxin A from Pseudomonas aeruginosa the target protein is elongation factor 2 (EF-2) (1). ADP-ribosylation inactivates the factor, thereby inhibiting protein synthesis and ultimately causing cell death. For cholera toxin and related enterotoxins the target is a subunit of the adenylate cyclase system (2). ADP-ribosylation enhances the activity of the cyclase, and the resulting increase in cAMP concentrations produces any of a variety of physiological changes, depending upon the type of cell affected. Recently, pertussis toxin has also been shown to ADP-ribosylate a component of adenylate cyclase (3).DT (Mr, 58,342) is released from Corynebacterium diphtheriae as a single, 535-residue polypeptide of known primary structure (4, 5). The intact toxin is inactive in catalyzing the ADP-ribosylation of EF-2 and must be subjected to mild proteolysis and reduction for this activity to be expressed. Such treatment cleaves the toxin into an enzymically active A fragment (Mr,21,167), and a B fragment (Mr, 37,195) involved in receptor recognition and membrane translocation.In earlier studies we characterized the enzymic and ligandbinding properties of fragment A (6). The . Both the efficiency of labeling (approaching 1 mol/mol) and the specificity of attachment are significan...